Gives the skin a visible glow
Suspected adverse reactions to any medicine or unlicensed product should be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Also Known As DSIP / Delta-Sleep-Inducing Peptide DSIP-LI (DSIP-like immunoreactivity used in assay contexts) Deltaran (Russian medical product name) CAS No
Its clinical development was nonetheless discontinued, and it is not an approved medicine
Get specific dosing for each component and timing strategies to maximize synergy while maintaining proper storage for all compounds
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain